Bartonellosis is a group of infectious diseases caused by bacteria from the Bartonella family, transmitted through insect bites, cat scratches, or other animal contact. These infections can cause symptoms ranging from mild fever and swollen glands to serious heart and brain complications, depending on which bacterial species is involved and the state of a person’s immune system.

Understanding Bartonellosis: Treatment Goals and Patient Care

When someone is diagnosed with bartonellosis, the main treatment goals focus on controlling symptoms, preventing complications, and helping the body eliminate the infection. For some people, especially those with healthy immune systems and milder forms of the disease, the infection may resolve on its own within a few weeks or months. However, others—particularly those with weakened immunity or severe symptoms—require medical intervention to prevent the disease from spreading to vital organs like the heart, brain, eyes, or liver.^[1][2]

Treatment strategies depend heavily on which species of Bartonella bacteria is causing the infection and how advanced the disease has become. A person with cat scratch disease may only need observation and supportive care, while someone with heart valve infection (endocarditis) or severe organ involvement requires aggressive antibiotic therapy and possibly surgery. The patient’s age, immune status, and overall health also influence treatment decisions.^[3][4]

Medical societies and healthcare guidelines recognize several standard antibiotic treatments that have been used successfully for decades, particularly for common forms like cat scratch disease. At the same time, researchers continue to explore better diagnostic tools and treatment approaches, as Bartonella infections can be difficult to detect and sometimes persist despite therapy. Understanding both established treatments and emerging research helps patients and doctors make informed decisions about care.^[5][6]

Standard Treatment Approaches for Bartonellosis

Treatment of Cat Scratch Disease (Bartonella henselae)

Cat scratch disease, caused by Bartonella henselae, is the most common form of bartonellosis in the United States, affecting approximately 20,000 people each year. For people with healthy immune systems who develop typical symptoms—such as a bump at the scratch site and swollen lymph nodes nearby—doctors often recommend watchful waiting rather than immediate antibiotic treatment. This is because the condition typically resolves on its own within two to four months without causing lasting harm.^[7][14]

When antibiotics are prescribed, the most commonly used medication is azithromycin. This antibiotic belongs to a class called macrolides and has been shown in clinical studies to help reduce the size of swollen lymph nodes more quickly than no treatment. The typical dosing schedule is 500 milligrams on the first day, followed by 250 milligrams daily for four more days in adults and older children. For younger children, the dose is calculated based on body weight—10 milligrams per kilogram on day one, then 5 milligrams per kilogram for the next four days.^[14][11]

Other antibiotics that may be used include doxycycline, erythromycin, co-trimoxazole (a combination of sulfamethoxazole and trimethoprim), or fluoroquinolone antibiotics like ciprofloxacin. The choice often depends on the patient’s age, whether they can tolerate certain medications, and how they respond to initial treatment. Treatment typically lasts three to six weeks, though some cases may require longer therapy, especially if bacteria have entered the bloodstream.^[10][11]

For people with weakened immune systems—such as those with HIV/AIDS, cancer patients undergoing chemotherapy, or organ transplant recipients—the disease can become much more severe. These patients may develop bacillary angiomatosis, a condition where blood vessels proliferate abnormally, creating tumor-like masses in skin, bones, and organs. Treatment requires longer courses of antibiotics, often three months or more, and may need to continue even longer to prevent relapse.^[5][9]

Treatment of Carrión’s Disease (Bartonella bacilliformis)

Carrión’s disease occurs in the Andes mountain regions of South America, particularly Peru, Colombia, and Ecuador. It is transmitted by sand fly bites and has two distinct phases. The acute phase, called Oroya fever, is life-threatening and causes high fever and severe destruction of red blood cells, leading to profound anemia. Without treatment, up to 40 to 90 percent of patients may die during this phase.^[2][4]

Chloramphenicol has been the standard antibiotic treatment for decades in areas where Carrión’s disease is common, partly because it is affordable and widely available in developing countries. However, ciprofloxacin and doxycycline are also effective alternatives. Treatment should continue for at least one week, and sometimes longer if the patient remains severely ill. Because the immune system becomes temporarily suppressed during Oroya fever, patients are at high risk for secondary infections, particularly from Salmonella bacteria. Doctors often need to treat these additional infections simultaneously.^[11][10]

The chronic phase of Carrión’s disease, known as verruga peruana, causes reddish-purple nodules to erupt on the skin, sometimes lasting for months. These skin lesions are not usually life-threatening but can be numerous and disfiguring. Antibiotics may help reduce the number and size of these nodules, though the lesions sometimes resolve on their own over time.^[9]

Treatment of Trench Fever (Bartonella quintana)

Trench fever, caused by Bartonella quintana, is transmitted by body lice and tends to occur in crowded conditions with poor sanitation and hygiene. Historically widespread during World War I and World War II, it now primarily affects people experiencing homelessness or living in refugee camps. The disease causes recurring bouts of fever, severe headaches, bone pain (especially in the shins and back), and sometimes a rash on the abdomen.^[6][7]

For uncomplicated trench fever, doxycycline 100 milligrams taken twice daily is the recommended treatment, typically continued for at least four weeks. In immunocompromised patients or those with more severe disease, treatment may need to last longer. Some patients develop chronic bacteremia, meaning bacteria persist in the bloodstream for months or years, which requires extended antibiotic therapy to fully clear the infection.^[10][11]

Treatment of Endocarditis and Severe Complications

When Bartonella bacteria infect heart valves, the resulting condition—endocarditis—is serious and potentially fatal. This complication can occur with multiple Bartonella species, but is most commonly seen with B. henselae and B. quintana. Patients with pre-existing heart valve damage, artificial heart valves, or weakened immune systems are at highest risk.^[5][15]

Treatment of Bartonella endocarditis requires aggressive combination antibiotic therapy. The standard regimen includes doxycycline for at least six weeks, combined with either gentamicin or rifampin (also called rifampicin) for at least the first 14 days. Gentamicin is an aminoglycoside antibiotic given by injection or infusion into a vein, and it requires careful monitoring because it can damage the kidneys and inner ear structures responsible for hearing and balance. Rifampin is an oral medication that penetrates tissues well and helps kill bacteria hiding inside cells.^[10][11]

Many patients with Bartonella endocarditis eventually require heart valve surgery to remove or replace the damaged valve tissue. Even with appropriate antibiotic therapy, the infection can cause such severe valve destruction that the heart cannot pump blood effectively. Surgically removed valves can be tested in the laboratory to confirm the presence of Bartonella bacteria, which helps guide continued treatment after surgery.^[13][15]

When Bartonella affects the brain or nervous system, causing conditions like encephalopathy (brain dysfunction), myelitis (spinal cord inflammation), or seizures, treatment becomes even more complex. Doctors prefer antibiotics that can cross the blood-brain barrier, such as doxycycline, azithromycin, rifampin, or certain fluoroquinolone antibiotics. If the infection affects the eyes, causing neuroretinitis (inflammation of the retina and optic nerve), the standard approach is doxycycline plus rifampin for four to six weeks. Some specialists also add corticosteroid medications to reduce inflammation, though this remains somewhat controversial.^[11][13]

Common Side Effects of Antibiotic Treatment

All antibiotics can cause side effects, and those used for bartonellosis are no exception. Azithromycin commonly causes stomach upset, nausea, and diarrhea, though these effects are usually mild. Doxycycline can make skin more sensitive to sunlight, increasing the risk of severe sunburn, and it should not be given to pregnant women or young children because it can permanently stain developing teeth. Chloramphenicol can suppress bone marrow function, reducing production of blood cells, so patients receiving this medication need regular blood count monitoring.^[10]

Rifampin commonly causes urine, tears, and other body fluids to turn orange-red in color, which is harmless but can stain contact lenses and clothing. It also interacts with many other medications, including birth control pills, making them less effective. Gentamicin requires careful kidney function monitoring and sometimes hearing tests because it can cause permanent kidney damage or hearing loss if levels become too high in the bloodstream.^[11]

Treatment Approaches Being Studied in Clinical Trials

While standard antibiotic treatments work well for many cases of bartonellosis, researchers continue to investigate better diagnostic methods, new treatment strategies, and ways to manage difficult or persistent infections. These investigations take place in clinical trials, which are carefully designed research studies that test whether new approaches are safe and effective before they become widely available.

Improved Diagnostic Testing Methods

One major area of research focuses on developing better ways to detect Bartonella infections. Current blood tests looking for antibodies against Bartonella bacteria have significant limitations—they sometimes give false negative results in people who truly have the infection, and they can give false positive results in people who were infected in the past but no longer have active disease. Moreover, these antibody tests often cannot distinguish between different Bartonella species, making it hard to determine exactly which bacteria is causing illness.^[3][13]

Researchers have been refining polymerase chain reaction (PCR) testing, which looks directly for bacterial DNA rather than the body’s antibody response. PCR can identify specific Bartonella species and may detect infection earlier than antibody tests. However, because Bartonella bacteria often hide inside cells and may be present in low numbers in the bloodstream, PCR tests on blood samples sometimes miss the infection. Scientists are exploring ways to improve PCR sensitivity, such as testing multiple blood samples over time or using enrichment culture techniques that allow bacteria to multiply before testing.^[10][13]

Some research teams are developing more sophisticated antibody tests, including Western blot assays that can detect specific Bartonella proteins and may have better accuracy than older test methods. Other investigators are examining whether testing different types of samples—such as spinal fluid when neurological symptoms are present, or tissue biopsies from skin lesions or lymph nodes—might improve detection rates.^[3]

Alternative Antibiotic Regimens

Although established antibiotics like azithromycin and doxycycline work for many patients, some people continue to have symptoms despite standard treatment courses. This has prompted research into alternative antibiotic combinations and longer treatment durations. Clinical trials are examining whether certain fluoroquinolone antibiotics, such as levofloxacin or moxifloxacin, might be equally or more effective than current first-line treatments. These medications penetrate cells well and remain in the body longer, which could be advantageous against bacteria that hide inside human cells.^[11]

Some researchers are investigating combination therapy approaches that use two or three different antibiotics simultaneously from the start of treatment, rather than using single antibiotics or adding a second drug only if the first one fails. The reasoning is that bacteria may be less likely to persist if attacked by multiple drugs with different mechanisms of action. However, combination therapy also increases the risk of side effects and drug interactions, so careful study is needed to determine if the benefits outweigh the risks.^[10]

Understanding Chronic Infection and Neuropsychiatric Symptoms

Recent case reports have suggested that Bartonella species might cause chronic intravascular infections lasting months to years, potentially contributing to ongoing symptoms including fatigue, pain, and neuropsychiatric problems such as anxiety, depression, brain fog, and mood changes. Some patients diagnosed with chronic Lyme disease or similar conditions have tested positive for Bartonella when highly sensitive DNA-based tests were used.^[3][18]

Clinical investigators are studying whether extended antibiotic treatment—sometimes lasting several months—might help patients with suspected chronic Bartonella infections. One published case involved a 14-year-old boy with severe psychiatric symptoms including hallucinations and homicidal thoughts, whose condition completely resolved after prolonged treatment with multiple antibiotics including rifampin and rifabutin (a related drug). While such cases are compelling, larger controlled studies are needed to determine how common chronic Bartonella infection truly is and whether long-term antibiotic therapy provides consistent benefit.^[18]

This research is controversial because extended antibiotic use carries risks, including disruption of healthy gut bacteria, development of antibiotic-resistant bacteria, medication side effects, and significant costs. Some medical experts worry that attributing vague symptoms to chronic infections may lead patients away from other potentially helpful treatments. Clinical trials attempting to answer these questions must carefully weigh potential benefits against these concerns.^[13]

Immunomodulatory Approaches

Because Bartonella bacteria can suppress certain immune responses, some researchers are exploring whether treatments that enhance immunity might help the body clear infections more effectively. This could be particularly relevant for immunocompromised patients who struggle to eliminate Bartonella despite antibiotic therapy. For example, HIV patients with bartonellosis show much better outcomes when they receive effective antiretroviral therapy that restores immune function alongside antibiotics.^[11]

Scientists are investigating whether other immune-enhancing interventions might benefit patients who are not HIV-positive but still have difficulty clearing Bartonella. This remains in early research stages, with studies primarily being conducted in laboratory settings rather than in human patients.

Prevention Research and Vaccine Development

While not directly related to treating active infections, research into Bartonella prevention could eventually reduce the need for treatment. Scientists studying how these bacteria are transmitted between animals and to humans hope to identify better control strategies. For Carrión’s disease, vector control programs targeting sand flies in endemic regions have shown promise. For cat scratch disease, efforts to control fleas in cat populations could reduce transmission risk.^[1][7]

No vaccines against Bartonella species currently exist, but research into the bacteria’s surface proteins and how the immune system recognizes them could eventually lead to vaccine development. This would be particularly valuable for Carrión’s disease in South American regions where it remains a significant public health problem.

Geographic Distribution of Clinical Research

Clinical trials investigating bartonellosis treatments are conducted in various locations worldwide. In the United States, research centers in California, Texas, and other states with expertise in vector-borne diseases are actively studying improved diagnostics and treatments. In South America, particularly Peru, research institutions focus on Carrión’s disease, conducting trials of new antibiotics and prevention strategies. European centers, especially in France, have made significant contributions to understanding Bartonella endocarditis and developing treatment recommendations. Patients interested in participating in clinical trials should discuss options with their healthcare providers or search clinical trial registries to find studies recruiting participants in their region.^[10][11]

Most common treatment methods

• Macrolide antibiotics
  • Azithromycin (most commonly used for cat scratch disease; typical course is 500mg on day 1, then 250mg daily for 4 days)
  • Erythromycin (alternative macrolide option for cat scratch disease)
  • Clarithromycin (sometimes used for bacillary angiomatosis or as alternative treatment)
• Tetracycline antibiotics
  • Doxycycline (used for trench fever, endocarditis, and severe complications; typical dose 100mg twice daily for at least 4 weeks)
  • Effective against multiple Bartonella species and penetrates tissues well
• Rifamycin antibiotics
  • Rifampin (rifampicin) combined with other antibiotics for endocarditis and severe disease
  • Rifabutin (related medication sometimes used for persistent or chronic infections)
  • These drugs penetrate cells effectively and are often used in combination therapy
• Fluoroquinolone antibiotics
  • Ciprofloxacin (effective for Carrión’s disease and sometimes used as alternative for other forms)
  • Levofloxacin and moxifloxacin (being studied as potential alternatives to standard treatments)
• Aminoglycoside antibiotics
  • Gentamicin (used for first 14 days in combination treatment of endocarditis)
  • Requires intravenous administration and careful monitoring for kidney and hearing effects
• Other antibiotics
  • Chloramphenicol (standard treatment for Carrión’s disease in South America)
  • Co-trimoxazole or trimethoprim-sulfamethoxazole (alternative option for some forms of bartonellosis)
• Supportive care and watchful waiting
  • For mild cat scratch disease in healthy individuals, observation without antibiotics is often recommended
  • Symptoms typically resolve within 2-4 months without treatment
  • Lymph node aspiration may be performed if nodes become very painful or filled with pus
• Surgical intervention
  • Heart valve replacement surgery for endocarditis when valve damage is severe
  • Usually performed in combination with prolonged antibiotic therapy